Aethlon Medical, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Aethlon Medical, Inc. now
Current reporting with the operating signal separated from the noise.
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
Investors are testing whether Aethlon Medical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aethlon Medical, Inc.: Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
The story matters when it changes Aethlon Medical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
The story matters when it changes Aethlon Medical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
The story matters when it changes Aethlon Medical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
The story matters when it changes Aethlon Medical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: regulator filings, verified operating scope and liability disclosures.Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript
Investors are testing whether Aethlon Medical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call Transcript
Investors are testing whether Aethlon Medical, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aethlon Medical, Inc. (AEMD) Approaching A Major Catalyst With Hemopurifier Trial
The story matters when it changes Aethlon Medical, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest AEMD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Aethlon Medical, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →